Delivery Order SPE2DB20D3101-SPE2DB22FJ9D3
Award Date
5/24/22
Potential Completion Date
5/25/22
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,704.75 and runs through February 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract is a delivery order under a larger...
This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $43,509.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the...
This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,201.01 and an ultimate completion date of April 25, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA) with a total ceiling value of $10,697.65. The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract was awarded on October 26, 2021, with an ultimate completion date of October 27, 2021, and is a firm fixed-price delivery order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,288.49 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of September 25, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). AmerisourceBergen holds a...
This federal contract award is for the delivery of Xifaxan 550 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $62,408.54 firm fixed-price contract was awarded on June 21, 2024 to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, with a completion date of June 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xifaxan 550 mg tablets. The $7,918.17 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award is for the delivery of Xifaxan 550 mg tablets to support Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,791.73 and runs through March 27, 2023. It is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the pharmaceutical product Xifaxan 550 mg tablets, awarded by the Defense Logistics Agency (DLA) to prime contractor AmerisourceBergen Drug Corp. The single-award delivery order contract has a ceiling value of $5,814.46 and a completion date of February 12, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of Xifaxan 550 mg tablets to support military and veterans' healthcare programs. The $8,613.32 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...